1. Home
  2. BGLC vs NEXR Comparison

BGLC vs NEXR Comparison

Compare BGLC & NEXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$1.51

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

NEXR

Nexera Technologies Ltd Ordinary Shares

N/A

Current Price

$2.80

Market Cap

4.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
BGLC
NEXR
Founded
2017
N/A
Country
Malaysia
Israel
Employees
N/A
38
Industry
Medical Specialities
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.2M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
BGLC
NEXR
Price
$1.51
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.5K
2.4M
Earning Date
04-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$7,424,911.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.23
52 Week High
$6.10
$5.28

Technical Indicators

Market Signals
Indicator
BGLC
NEXR
Relative Strength Index (RSI) 42.26 70.20
Support Level $1.22 $2.32
Resistance Level $2.72 $5.28
Average True Range (ATR) 0.10 0.54
MACD 0.04 0.22
Stochastic Oscillator 69.05 50.81

Price Performance

Historical Comparison
BGLC
NEXR

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

Share on Social Networks: